GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $485,000 | +98.8% | 11,049 | +100.0% | 0.02% | 0.0% |
Q4 2021 | $244,000 | +18.4% | 5,524 | +2.5% | 0.02% | 0.0% |
Q3 2021 | $206,000 | -10.0% | 5,388 | -6.4% | 0.02% | -27.3% |
Q2 2021 | $229,000 | +12.8% | 5,758 | +4.2% | 0.03% | -17.5% |
Q4 2020 | $203,000 | -38.1% | 5,526 | -20.8% | 0.04% | -55.6% |
Q4 2019 | $328,000 | +10.4% | 6,973 | +0.3% | 0.09% | -6.2% |
Q3 2019 | $297,000 | +6.1% | 6,955 | -0.5% | 0.10% | +15.7% |
Q2 2019 | $280,000 | -0.4% | 6,990 | +4.0% | 0.08% | -2.4% |
Q1 2019 | $281,000 | +9.8% | 6,721 | +0.2% | 0.08% | +9.0% |
Q4 2018 | $256,000 | -21.0% | 6,706 | -16.8% | 0.08% | +9.9% |
Q3 2018 | $324,000 | +1.2% | 8,060 | +1.6% | 0.07% | -7.8% |
Q2 2018 | $320,000 | +6.0% | 7,935 | +2.8% | 0.08% | +30.5% |
Q1 2018 | $302,000 | +19.8% | 7,719 | +8.7% | 0.06% | -1.7% |
Q4 2017 | $252,000 | -23.9% | 7,104 | -12.9% | 0.06% | -25.9% |
Q3 2017 | $331,000 | -4.9% | 8,154 | +0.9% | 0.08% | +11.0% |
Q2 2017 | $348,000 | +9.4% | 8,079 | +7.3% | 0.07% | 0.0% |
Q1 2017 | $318,000 | -4.8% | 7,532 | -13.1% | 0.07% | +1.4% |
Q4 2016 | $334,000 | -16.9% | 8,670 | -8.1% | 0.07% | -25.0% |
Q3 2016 | $402,000 | +0.8% | 9,439 | +2.4% | 0.10% | -1.0% |
Q2 2016 | $399,000 | -1.7% | 9,217 | -7.9% | 0.10% | -4.0% |
Q1 2016 | $406,000 | -7.1% | 10,007 | -7.5% | 0.10% | -3.8% |
Q4 2015 | $437,000 | -8.2% | 10,819 | -12.7% | 0.10% | -15.3% |
Q3 2015 | $476,000 | -14.7% | 12,389 | -7.6% | 0.12% | -13.9% |
Q2 2015 | $558,000 | -11.3% | 13,409 | -1.5% | 0.14% | -11.1% |
Q1 2015 | $629,000 | -10.3% | 13,619 | -17.0% | 0.16% | -11.0% |
Q4 2014 | $701,000 | +47.6% | 16,410 | +58.7% | 0.18% | +28.2% |
Q3 2014 | $475,000 | -14.1% | 10,343 | 0.0% | 0.14% | -14.5% |
Q2 2014 | $553,000 | -3.3% | 10,343 | -3.3% | 0.17% | -11.2% |
Q1 2014 | $572,000 | +41.9% | 10,698 | +41.8% | 0.19% | +37.5% |
Q4 2013 | $403,000 | +82.4% | 7,543 | +71.5% | 0.14% | +97.1% |
Q3 2013 | $221,000 | -31.2% | 4,398 | -31.5% | 0.07% | -38.4% |
Q2 2013 | $321,000 | – | 6,423 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |